Probiotic Therapy in Patients with Nonalcoholic Steatohepatitis in Zagazig University Hospitals
Open Access
- 1 June 2017
- journal article
- Published by Jaypee Brothers Medical Publishing in Euroasian Journal of Hepato-Gastroenterology
- Vol. 7 (1) , 101-106
Abstract
Aim: Nonalcoholic fatty liver disease (NAFLD) is probably the most common liver disorder in the world. A subgroup of NAFLD patients is characterized by injury to the hepatocytes and inflammation in addition to excessive fat (steatohepatitis), the latter condition is nominated nonalcoholic steatohepatitis (NASH). This work aimed to evaluate the role of probiotics on the outcome of NASH in patients admitted to the Tropical Medicine Department, Faculty of Medicine, Zagazig University (inpatients and outpatients). Materials and methods: This study was performed on 30 patients (17 males and 13 females), with body mass index from 30 to 35 and average age of 44 years with bright fatty liver in ultrasonography and raised alanine transaminase (ALT) and aspartate transaminase (AST) and positive liver biopsy findings. The patients were divided into group I (case group) that included 15 patients who received probiotics and group II of 15 patients as control group who did not receive probiotics; the study was conducted between November 2014 and April 2016. Clinical assessment, laboratory evaluation, pelvic-abdominal ultrasound, and liver biopsy of all cases were carried out. Results: In this study, there was significant decrease in liver enzymes (ALT and AST) and no statistically significant other laboratory findings. Also there was relief for dyspepsia in some patients. Conclusion: Probiotics treatment is effective, safe, well-tolerated, inexpensive, appropriate for long-term use, and optimally, works at multiple levels to downregulate inflammatory mediators, and therefore, probiotics could be an option in the treatment of NASH. How to cite this article: Monem SMA. Probiotic Therapy in Patients with Nonalcoholic Steatohepatitis in Zagazig University Hospitals. Euroasian J Hepato-Gastroenterol 2017;7(1):101-106.Keywords
This publication has 22 references indexed in Scilit:
- Nonalcoholic steatohepatitis versus steatosis: Adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolismHepatology, 2012
- Recent advances in nonalcoholic fatty liver diseaseCurrent Opinion in Gastroenterology, 2010
- Fatty liver and the metabolic syndromeCurrent Opinion in Gastroenterology, 2007
- Beneficial Effects of a Probiotic VSL#3 on Parameters of Liver Dysfunction in Chronic Liver DiseasesJournal of Clinical Gastroenterology, 2005
- Nonalcoholic fatty liver disease: An agenda for clinical researchHepatology, 2002
- Cytokines in Alcoholic and Nonalcoholic SteatohepatitisNew England Journal of Medicine, 2000
- Endotoxin and Alcoholic Liver Disease: Tolerance and SusceptibilityHepatology, 1999
- Does probiotics administration decrease serum endotoxin levels in infants?Journal of Pediatric Surgery, 1999
- Idiopathic steatohepatitis in childhood: A multicenter retrospective studyThe Journal of Pediatrics, 1995
- Antibiotics prevent liver injury in rats following long-term exposure to ethanolGastroenterology, 1995